Rua Bioscience

Rua Bioscience EBITDA per Employee

EBITDA per Employee of Rua Bioscience (RUA.NZ) as of Oct 23, 2026.

EBITDA per Employee

-NZD

Last updated:

EBITDA per Employee of Rua Bioscience is 2026 - NZD. EBITDA per Employee of Rua Bioscience was 2025 - NZD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rua Bioscience Stock analysis

What does Rua Bioscience do? Rua Bioscience Ltd develops medical cannabis products through research and development, breeding, cultivation, manufacturing, and distribution. The company focuses on medicinal cannabis for Germany and New Zealand, operating one segment that includes R&D and pharmaceutical sales. Its full research laboratory in Gisborne handles cannabinoid testing, microscopic analysis, moisture analysis, sample preparation, extraction, solvent removal, viscosity measurements, and impurity testing. The company generates revenue from the sale of pharmaceutical products in Germany and New Zealand, targeting healthcare providers and patients seeking medical cannabis treatments. R&D activities support product development and regulatory compliance, while the Gisborne laboratory ensures quality control through comprehensive testing services. Rua Bioscience Ltd's primary customers are healthcare providers and patients in Germany and New Zealand who require medicinal cannabis solutions. The firm's products are distributed through pharmaceutical channels, with the Gisborne laboratory providing essential testing to meet market standards and regulatory requirements. Rua Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rua Bioscience stock

On Eulerpool you can find the complete historical development of EBITDA per Employee Rua Bioscience since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's NZD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Rua Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Rua Bioscience

All Key Metrics — Rua Bioscience